Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

Actinogen makes landmark discovery of possible pathogenic fungi killer

Actinogen (ASX: ACW) has made a discovery that could have potential commercial applications in the elimination of pathogenic fungi that kills crops, grains, plantations and possibly even dieback in forests.

The company has isolated, from Western Australian soil, a small series of actinomycetes that have the ability to synthesize volatile bioactive molecules (polyenes).

The actinomycetes producing polyenes may be able to be used to naturally biofumigate soils to stop the infection of plants and grasses with pathogenic fungi.

Polyenes are a group of compounds often produced by microorganisms. These compounds can be volatile or not and have been shown to exhibit bacterial antibiotic properties over a wide range of microorganisms.

They are used as human and animal antibiotics and plants directed against pathogens including bacteria and fungi.

Actinogen has applied for an Australian provisional patent covering the discovery and is now seeking commercial partners.

Proactive Investors is a market leader in the investment news space, providing ASX “Small and Mid-cap” company news, research reports, StockTube videos and One2One Investor Forums.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK